KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardlytics (CDLX) Total Non-Current Liabilities (2017 - 2024)

Cardlytics (CDLX) has disclosed Total Non-Current Liabilities for 8 consecutive years, with $322.7 million as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Total Non-Current Liabilities fell 26.53% year-over-year to $322.7 million, compared with a TTM value of $322.7 million through Dec 2024, down 26.53%, and an annual FY2024 reading of $322.7 million, down 26.53% over the prior year.
  • Total Non-Current Liabilities was $322.7 million for Q4 2024 at Cardlytics, down from $329.7 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $568.5 million in Q4 2021 and bottomed at $264.7 million in Q4 2020.
  • Average Total Non-Current Liabilities over 5 years is $425.3 million, with a median of $459.5 million recorded in 2022.
  • The sharpest move saw Total Non-Current Liabilities surged 226.56% in 2020, then fell 26.53% in 2024.
  • Year by year, Total Non-Current Liabilities stood at $264.7 million in 2020, then skyrocketed by 114.82% to $568.5 million in 2021, then fell by 15.64% to $479.6 million in 2022, then fell by 8.41% to $439.3 million in 2023, then dropped by 26.53% to $322.7 million in 2024.
  • Business Quant data shows Total Non-Current Liabilities for CDLX at $322.7 million in Q4 2024, $329.7 million in Q3 2024, and $324.3 million in Q2 2024.